Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

MAPRE1 protein, human × Breast × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2 Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Paclitaxel 141 Fulvestrant 138 Trastuzumab 135 pembrolizumab 124 Letrozole 120 Carboplatin 103 Capecitabine 91 Specimen Handling 88 Cyclophosphamide 88 pertuzumab 83 Anastrozole 78 Docetaxel 77 Magnetic Resonance Spectroscopy 76 abemaciclib 73 palbociclib 66 Tamoxifen 65 exemestane 63 ribociclib 61 trastuzumab deruxtecan 60 Radiotherapy 59 Biopsy 52 olaparib 48 Surveys and Questionnaires 48 130-nm albumin-bound paclitaxel 46 sacituzumab govitecan 45 Gemcitabine 43 Doxorubicin 43 Blood Specimen Collection 43 eribulin 41 Standard of Care 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06067061 2025-06-11

neoBREASTIM

Institut Curie

Phase 1/2 Terminated

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡